|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-7-15
|
|
pubmed:abstractText |
Darinaparsin is a novel organic arsenic that reaches higher intracellular concentration with decreased toxicity compared to inorganic arsenic. We conducted a multi-center phase II study with darinaparsin in patients with advanced HCC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1573-0646
|
|
pubmed:author |
pubmed-author:AbbadessaGiovanniG,
pubmed-author:BlaszkowskyLawrence SLS,
pubmed-author:ChenHaobinH,
pubmed-author:CostaMaxM,
pubmed-author:FeunLynnL,
pubmed-author:GoldPhilipP,
pubmed-author:HendersonCharlesC,
pubmed-author:HochsterHowardH,
pubmed-author:LewisJonathanJ,
pubmed-author:MuggiaFrancoF,
pubmed-author:NierodzikMaryLynnM,
pubmed-author:RosenzweigBarryB,
pubmed-author:RyanTheresaT,
pubmed-author:Van VeldhuizenPeterP,
pubmed-author:WuJenniferJ,
pubmed-author:ZhengHuiH,
pubmed-author:ZhuAndrew XAX
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
670-6
|
|
pubmed:meshHeading |
pubmed-meshheading:19565187-Adult,
pubmed-meshheading:19565187-Aged,
pubmed-meshheading:19565187-Antineoplastic Agents,
pubmed-meshheading:19565187-Arsenicals,
pubmed-meshheading:19565187-Carcinoma, Hepatocellular,
pubmed-meshheading:19565187-Disease-Free Survival,
pubmed-meshheading:19565187-Female,
pubmed-meshheading:19565187-Glutathione,
pubmed-meshheading:19565187-Humans,
pubmed-meshheading:19565187-Liver Neoplasms,
pubmed-meshheading:19565187-Male,
pubmed-meshheading:19565187-Middle Aged,
pubmed-meshheading:19565187-Neoplasm Staging,
pubmed-meshheading:19565187-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma.
|
|
pubmed:affiliation |
Department of Medical Oncology, NYU School of Medicine, New York, NY, USA. Jennifer.wu@nyumc.org
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
